61 Nonetheless, a numerical trend in favour of combination therapy was noted, which the authors suggested might have clinical value in selected high-risk patients with residual disease activity despite bDMARD therapy.
1
—
—
61 Nonetheless, a numerical trend in favour of combination therapy was noted, which the authors suggested might have clinical value in selected high-risk patients with residual disease activity despite bDMARD therapy.